Medicare Advantage Open Enrollment Period (OEP)

The Medicare Advantage Open Enrollment Period (OEP) is a period during which Medicare beneficiaries who are enrolled in a Medicare Advantage Plan can make changes to their coverage. It occurs annually from January 1 to March 31.

During the OEP, beneficiaries who are enrolled in a Medicare Advantage Plan can make the following changes to their coverage:

• Switch to a different Medicare Advantage Plan: Beneficiaries can switch to a different Medicare Advantage Plan that has a 5-star rating or enroll in a different Medicare Advantage Plan that is available in their service area.

• Drop their Medicare Advantage Plan and return to Original Medicare: Beneficiaries can also drop their Medicare Advantage Plan and return to Original Medicare. They can also enroll in a standalone Medicare Part D prescription drug plan.

It's important to note that the OEP is different from the Annual Enrollment Period (AEP), which occurs from October 15 to December 7 each year. During the AEP, beneficiaries can switch from Original Medicare to a Medicare Advantage Plan, switch from one Medicare Advantage Plan to another, or enroll in a Medicare Part D prescription drug plan.

Also, not all beneficiaries are eligible for the OEP. Those who are already enrolled in Original Medicare with a standalone Medicare Part D prescription drug plan are not eligible. The OEP is only available to those who are enrolled in a Medicare Advantage Plan.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.